Ubs Group Ag Neuro Sense Therapeutics Ltd. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 1,611 shares of NRSN stock, worth $1,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,611

Previous 2,275 29.19%

Holding current value

$1,900

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.91 - $2.49 $604 - $1,653	-664 Reduced 29.19%	1,611 $3,000
Q1 2025 May 13, 2025	BUY	$0.93 - $1.21 $2,115 - $2,752	2,275 New	2,275 $2,000
Q1 2024 May 13, 2024	BUY	$0.78 - $2.11 $5,016 - $13,571	6,432 Added 117.03%	11,928 $21,000
Q4 2023 Feb 09, 2024	SELL	$0.44 - $1.49 $1,834 - $6,211	-4,169 Reduced 43.14%	5,496 $4,000
Q3 2023 Nov 09, 2023	BUY	$0.71 - $1.47 $6,862 - $14,207	9,665 New	9,665 $6,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.22 $836 - $1,547	697 Added 17.15%	4,762 $8,000
Q4 2022 Feb 08, 2023	BUY	$1.22 - $1.9 $2,730 - $4,252	2,238 Added 122.5%	4,065 $4,000
Q3 2022 Nov 10, 2022	SELL	$1.6 - $3.3 $18,561 - $38,283	-11,601 Reduced 86.39%	1,827 $3,000
Q2 2022 Aug 10, 2022	BUY	$1.24 - $3.76 $14,314 - $43,405	11,544 Added 612.74%	13,428 $45,000
Q1 2022 May 16, 2022	SELL	$1.33 - $6.23 $8,158 - $38,214	-6,134 Reduced 76.5%	1,884 $7,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $4.04 $19,243 - $32,392	8,018 New	8,018 $20,000

Others Institutions Holding NRSN

# of Institutions

Shares Held

443K

Call Options Held

Put Options Held

View Full List

About NeuroSense Therapeutics Ltd.

Ticker NRSN
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,674,000
Market Cap $13.8M

More about NRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account